» Articles » PMID: 31311827

Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation

Overview
Journal Mol Cancer Res
Specialty Cell Biology
Date 2019 Jul 18
PMID 31311827
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase D1 (PKD1) is a serine/threonine kinase that belongs to the calcium/calmodulin-dependent kinase family, and is involved in multiple mechanisms implicated in tumor progression such as cell motility, invasion, proliferation, protein transport, and apoptosis. While it is expressed in most tissues in the normal state, PKD1 expression may increase or decrease during tumorigenesis, and its role in proliferation is context-dependent and poorly understood. In this review, we present and discuss the current landscape of studies investigating the role of PKD1 in the proliferation of both cancerous and normal cells. Indeed, as a potential therapeutic target, deciphering whether PKD1 exerts a pro- or antiproliferative effect, and under what conditions, is of paramount importance.

Citing Articles

Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma.

Han X, Sui J, Nie K, Zhao Y, Lv X, Xie J Leukemia. 2024; 38(10):2276-2280.

PMID: 39080353 DOI: 10.1038/s41375-024-02349-w.


Potential role for protein kinase D inhibitors in prostate cancer.

Chalfant V, Riveros C, Singh P, Shukla S, Balaji N, Balaji K J Mol Med (Berl). 2023; 101(4):341-349.

PMID: 36843036 DOI: 10.1007/s00109-023-02298-4.


Protein kinase D1 overexpression potentiates epidermal growth factor signaling pathway in MCF-7 cells.

Legay C, Doublier S, Babajko S, Ricort J Mol Biol Rep. 2023; 50(4):3641-3651.

PMID: 36800056 DOI: 10.1007/s11033-023-08300-z.


A Glance at the Molecules That Regulate Oligodendrocyte Myelination.

Wang S, Wang Y, Zou S Curr Issues Mol Biol. 2022; 44(5):2194-2216.

PMID: 35678678 PMC: 9164040. DOI: 10.3390/cimb44050149.


3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth.

Shukla S, Fletcher S, Chauhan J, Chalfant V, Riveros C, Mackeyev Y Cancer Gene Ther. 2022; 29(11):1550-1557.

PMID: 35440696 DOI: 10.1038/s41417-022-00455-4.